Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.

Journal article

OBJECTIVE: To explore the cost-effectiveness of parenteral artesunate for the treatment of severe malaria in children and its potential impact on hospital budgets. METHODS: The costs of inpatient care of children with severe malaria were assessed in four of the 11 sites included in the African Quinine Artesunate Malaria Treatment trial, conducted with over 5400 children. The drugs, laboratory tests and intravenous fluids provided to 2300 patients from admission to discharge were recorded, as ...

Expand abstract

Authors: Lubell, Y; Riewpaiboon, A; Dondorp, A; von Seidlein, L; Mokuolu, O

• Publication status: Published
• Journal: Bulletin of the World Health Organization
• Volume: 89
• Issue: 7
• Pages: 504-512
• Publication date: 2011-07-01
• DOI: 10.2471/blt.11.085878
• EISSN: 1564-0604
• ISSN: 0042-9686
• Language: English
• Keywords: Humans; Outcome Assessment (Health Care); Health Care Costs; Antimalarials; Africa South of the Sahara; Child; Artemisinins; Severity of Illness Index; Cost-Benefit Analysis; Malaria; Child, Preschool; Infusions, Parenteral